Apixaban + Clopidogrel Interaction
Majorinteraction on record
Description
Antiplatelet agent that increases bleeding risk when coadministered with apixaban. Dual antiplatelet therapy with apixaban resulted in 5.9% major bleeding per year versus 2.5% with placebo.
Mechanism
Additive antiplatelet effects
Source: NLP:apixaban